JKJianlong Ke

Jianlong Ke

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jianlong Ke has a total of 3 co-authors. Here are the top co-authors by number of shared publications:

  • Huimin Xu

    Acupuncture and Tuina School Chengdu University of Traditional Chinese Medicine Chengdu Sichuan China

    1 shared publication
  • Shaoquan Xiong

    Department of Oncology Hospital of Chengdu University of Traditional Chinese Medicine Chengdu Sichuan China

    1 shared publication
  • Yingzhe Luo

    Department of Oncology Hospital of Chengdu University of Traditional Chinese Medicine Chengdu Sichuan China

    1 shared publication

Latest Publications

  • Understanding Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Physical Fatigue Through the Perspective of Immunosenescence

    by Yingzhe Luo, Huimin Xu, Shaoquan Xiong, Jianlong Ke

    Background: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating illness marked by persistent fatigue, yet its mechanisms remain unclear. Growing evidence implicates immunosenescence—the age‐related decline in immune function—in the onset and persistence of fatigue. Methods: This review synthesizes clinical and experimental data to examine how immunosenescence contributes to ME/CFS. We focus on chronic inflammation, senescent immune phenotypes, mitochondrial dysfunction, and neuroendocrine imbalance, with emphasis on maladaptive crosstalk among immune, muscular, neuroendocrine, and vascular systems. Results: Aging immune cells drive chronic inflammation that impairs mitochondrial ATP production and promotes muscle catabolism. Concurrently, HPA‐axis suppression and β 2 ‐adrenergic dysfunction amplify immune dysregulation and energy imbalance. Together, these processes illustrate how immunosenescence sustains pathological cross‐organ signaling underlying systemic fatigue. Conclusion: Immunosenescence provides a unifying framework linking immune, metabolic, and neuroendocrine dysfunction in ME/CFS. Recognizing cross‐organ communication highlights its clinical relevance, suggesting biomarkers such as cytokines and exhaustion markers, and supports integrated therapeutic strategies targeting immune and metabolic networks.